Cat.#: ACPP-1209
| Despition | CaMKII gamma Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1326 | Galectin 3 Blocking Peptide (AC1326) | 250 µg | inquiry |
| ACPP-1661 | Human HEXA Protein, Sf9 (AC1661) | 2 µg | inquiry |
| ACPP-1193 | Human M2 Protein (AC1193) | 5 µg | inquiry |
| ACPP-1271 | Alpha Synuclein Blocking Peptide (AC1271) | 250 µg | inquiry |
| ACPP-1843 | Human PON1 Protein (AC1843) | 2 µg | inquiry |
| ACPP-1670 | Mouse BDNF Protein (AC1670) | 2 µg | inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
| ACPP-1300 | GTP cyclohydrolase 1 Blocking Peptide (AC1300) | 250 µg | inquiry |
| ACPP-1659 | Human Visfatin Protein (AC1659) | 5 µg | inquiry |
| ACPP-1331 | GPR56 Blocking Peptide (AC1331) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.